The prevalence and incidence of cardiovascular conditions in developed economies continue to increase, creating challenges and opportunities for cardiovascular drug developers. While the vast majority of drugs for treating cardiovascular conditions are oral immediate release products, issues related to drug safety and patient compliance have focused attention on formulations that can improve drug safety profiles and reduce dosing frequency. Important treatment segments for controlled release cardiovascular drugs include angina, hypertension, arrhythmias, cholesterol, and peripheral artery disease. Important growth factors for controlled release cardiovascular drugs include evolving patient demographics, environmental and lifestyle causative factors, increased public awareness of cardiovascular conditions and their associated morbidities, and expanded patient access to cardiovascular treatment services. Highlights ' Analyzes and evaluates cardiovascular drugs formulated for controlled release and assesses the market potential for existing and potential future products' Analyzes product technologies and product development factors' Provides detailed assessments of key cardiovascular market segments, market demographics and business strategies' Provides market data and forecasts to 2015' Profiles market sector participant companies, their product development activities and strategies

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Controlled Release Cardiovascular Therapeutics
Published on August 2011
Report Summary
The prevalence and incidence of cardiovascular conditions in developed economies continue to increase, creating challenges and
opportunities for cardiovascular drug developers. While the vast majority of drugs for treating cardiovascular conditions are oral
immediate release products, issues related to drug safety and patient compliance have focused attention on formulations that can
improve drug safety profiles and reduce dosing frequency. Important treatment segments for controlled release cardiovascular drugs
include angina, hypertension, arrhythmias, cholesterol, and peripheral artery disease. Important growth factors for controlled release
cardiovascular drugs include evolving patient demographics, environmental and lifestyle causative factors, increased public
awareness of cardiovascular conditions and their associated morbidities, and expanded patient access to cardiovascular treatment
services.
Highlights
' Analyzes and evaluates cardiovascular drugs formulated for controlled release and assesses the market potential for existing and
potential future products
' Analyzes product technologies and product development factors
' Provides detailed assessments of key cardiovascular market segments, market demographics and business strategies
' Provides market data and forecasts to 2015
' Profiles market sector participant companies, their product development activities and strategies
Table of Content
Summary of Contents
Executive Summary
Cardiovascular Therapeutics - Market Dynamics
The Cardiovascular Drug Landscape
Unmet Needs in Cardiovascular Clinical Treatment
Cardiovascular Drug Demand Drivers
Demographic Shifts
Evolving Drug Formulation Technology
Managed Care Initiatives
Growth in Self Administration
Modified Release Technologies and Product Segments
Oral
Advanced Film Coating Systems
Bead Systems
Controlled Release Cardiovascular Therapeutics (From Slideshare) Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Bi-layer Tablets
Tri-layer Tablets
Microtablets
Transdermal
Cardiovascular Controlled Release Product Analysis
Clonidine
Diltiazem
Isosorbide dinitrate
Isradipine
Metoprolol
Nicardipine
Nifedipine
Nitroglycerin
Nisoldipine
Pentoxifylline
Propanolol
Virapamil
Cardiovascular Drug Commercialization Factors
Cardiovascular Segments for Controlled Release Therapeutics
Angina
Cholesterol Management
Heart Rhythm
Atrial Fibrillation
Arrhythmias
Hypertension
Peripheral Artery Disease
Market Factors
Regulations and Approvals
Managed Care and Healthcare Economics
Alliances and Private Labeling
Sector Participant Company Profiles
Controlled Release Cardiovascular Therapeutics (From Slideshare) Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Controlled Release Cardiovascular Therapeutics
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 3 850.00 Quantity: _____
Site License--USD 5 500.00 Quantity: _____
Corporate License--USD 7 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Controlled Release Cardiovascular Therapeutics (From Slideshare) Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Controlled Release Cardiovascular Therapeutics (From Slideshare) Page 4/4